Review article
Sex hormones and urticaria

https://doi.org/10.1016/j.jdermsci.2008.04.002Get rights and content

Summary

Chronic urticaria is characterized by mast cells/basophils activation which initiate the inflammatory response. Pathogenetically, the disease may in many cases represent an autoimmune phenomenon. Altered function of the neuro-endocrine-immune system due to stress and other factors has also been implicated its pathogenesis. Sex hormones modulate immune and inflammatory cell functions, including mast cell secretion, and are regarded as responsible for gender and menstrual cycle phase-associated differential susceptibility and severity of some autoimmune and inflammatory diseases. Chronic urticaria is approximately twice more frequent in women than in men. In addition, urticaria may be associated with some diseases and conditions characterized by hormonal changes, including endocrinopathy, menstrual cycle, pregnancy, menopause and hormonal contraceptives or hormone replacement therapy. Hypersensitivity reactions to endogenous or exogenous female sex hormones have been implicated in the pathogenesis of urticarial lesions associated with estrogen and autoimmune progesterone dermatitis. We observed lower serum dehydroepiandrosterone sulfate (DHEA-S) concentration in patients with chronic urticaria with positive and negative response to autologous serum skin test. Thus, the influence of fluctuations in the hormonal milieu and altered sex hormone expression on the triggering-off, maintenance or aggravation of urticaria should be taken into account. In addition, the possible impact of estrogen mimetics, in the environment and in food, on the development of disease associated with mast cell activation must be considered. This review endeavours to outline what is known about the possible influence of sex hormones in the expression of urticaria.

Introduction

Urticaria is a common clinical disorder, pathophysiology based on mediators release from mast cells, predominantly histamine and subsequently an inflammatory response [1]. However, in most cases, aetiology of chronic urticaria is unknown; it is referred to as chronic idiopathic urticaria and in over one-third of cases the autoimmune pathogenic mechanism is proposed [2], [3]. Interestingly, altered functions of the neuro-endocrine-immune system due to stress and other factors seem to appear as a very interesting theory for urticaria pathogenesis [4]. Changes in hormones balance and expression may promote the immunological imbalance and skin function responsible for urticaria expression. For example, rare association between primary hyperparathyroidism and chronic urticaria has been described [5]. The association between chronic urticaria and autoimmune thyroiditis is frequent. l-Thyroxine reduces the symptoms of chronic urticaria associated with autoimmune thyroiditis (hypothyroid and euthyroid), suggesting a stimulatory effect of TSH able to produce considerable changes of the immune response and immune tolerance in such patients [6]. Higher expression of corticotropin-releasing hormone receptor-1 in the skin of chronic urticaria patients has been demonstrated [7]. It is known that urticaria may be associated with some diseases and/or triggered by some conditions characterized by sex hormone changes, including menstrual cycle, pregnancy, menopause, and hormonal contraceptives or hormone replacement therapy. However, the role of endogenous and exogenous sex hormones as well as estrogen mimetics in the disease pathogenesis are poorly understood.

Sex hormones are considered to be responsible for gender and menstrual cycle phase-associated differential susceptibility and severity of some immune-mediated and inflammatory diseases, including asthma, atopic dermatitis, and lupus [8], [9], [10], [11].

It is well known that fluctuations in sex hormone level associated with menstrual cycle, pregnancy, menopause and hormone administration can induce oedematous attacks in hereditary angioneurotic oedema (HANO) [12], [13], [14], [15]. Thus, it is important to consider also the possibility of the influence of sex hormones on chronic urticaria expression.

Chronic urticaria occurs approximately twice more frequently in women as compared to men [16], [17], suggesting that sex differences in hormonal milieu may play a role in this phenomenon.

Section snippets

The role of sex hormones in the immune system function and mast cells activity

Receptors for sex hormones have been identified on various immune and inflammatory cells suggesting that these hormones influence directly their functions. Sex hormones are involved in immune response by regulation of maturation, survival, activation and function of diverse immune cells; generally with estrogens as enhancers at least of the humoral immunity and androgens and progesterone as natural immune-suppressors [2], [18], [19], [20]. Estrogens have dose- and cell-type-specific effects on

Urticaria related to the sex hormones fluctuations during the menstrual cycle

It is well known that severity of some diseases varies with the menstrual cycle, suggesting some influence of sex hormones on the diseases expression. Especially, symptoms aggravate during the premenstrual period, however the underlining mechanism is poorly understood [8], [9], [10]. For example, premenstrual deterioration in asthma symptoms was observed in about one-third of asthmatic women [8]. Hormonal fluctuations during the menstrual cycle are also thought to play a role in the urticaria

Sex hormonal changes in chronic idiopathic urticaria and autoimmune chronic urticaria

Information on relation between sex hormonal changes and chronic idiopathic urticaria and chronic autoimmune urticaria is scarce. It has been demonstrated that serum concentration of dehydroepiandrosterone sulfate (DHEA-S) in patients suffering from chronic urticaria is significantly lower than in healthy subjects [48], [49], [50], [51]. It is then interesting to state whether urticaria expression is influenced by dehydroepiandrosterone or by its metabolites?

DHEA and DHEA-S are steroid hormones

Oral contraceptives and hormone replacement therapy

Immune system and skin functions are regulated by sex hormones. Exogenous sex hormones can affect these hormone-dependent functions.

It well documented that hormonal contraceptives influence hereditary angioedema [12], [13], [14], [15]. In addition, a case report describes a patient showing acquired deficiency of C1-INH upon hormone replacement therapy [59]. Decreased plasma concentration of C1 esterase inhibitor has been reported in women taking oral contraceptives [60].

However, it is unclear

Menopause

It is known, that the peak time of life for urticaria to begin is between the age of 11 and 40. Then the frequency of urticaria tends to decrease [67]. However, there are no studies available on prevalence of urticaria in perimenopausal, menopausal and postmenopausal women. Theoretically, the lack in fluctuation in endogenous sex hormones in the postmenopausal period might be responsible for less frequent prevalence of the disease compared to perimenopausal and menopausal period characterized

Pregnancy

Urticaria/angioedema may also occur in pregnant women, worsen with pregnancy in some patients and appear to improve in others [68]. Pruritic urticarial papules and plaques of pregnancy (PUPPP) should also be kept in differential diagnosis in pregnant women, especially in cases of urticarial lesions occurring in the third trimester [69].

Concluding remarks

Data regarding relation between urticaria and sex hormones are scarce. Urticaria may be associated with some diseases and conditions characterized by sex hormone changes, including menstrual cycle, pregnancy, menopause, and hormonal contraceptives or hormone replacement therapy, suggesting that fluctuations in hormonal milieu may play a role in pathogenesis of the disease. In addition, occurrence of chronic urticaria is approximately doubled in women as compared to frequency in men. Such

Conflict of interest statement

All authors declare no conflict of interest.

References (69)

  • H. Tapiero et al.

    Estrogens and environmental estrogens

    Biomed Pharmacother

    (2002)
  • A.J. Herzberg et al.

    Autoimmune progesterone dermatitis

    J Am Acad Dermatol

    (1995)
  • J.L. Snyder et al.

    Autoimmune progesterone dermatitis and its manifestation as anaphylaxis: a case report and literature review

    Ann Allergy Asthma Immunol

    (2003)
  • B.K. Moghadam et al.

    Autoimmune progesterone dermatitis and stomatitis

    Oral Surg Oral Med Oral Pathol Oral Radiol Endod

    (1998)
  • W.B. Shelley et al.

    Estrogen dermatitis

    J Am Acad Dermatol

    (1995)
  • O.A. Leylek et al.

    Estrogen dermatitis

    Eur J Obstet Gynecol Reprod Biol

    (1997)
  • A. Kasperska-Zajac et al.

    Serum concentration of dehydroepiandrosterone sulphate in female patients with chronic idiopathic urticaria

    J Dermatol Sci

    (2006)
  • A. Kasperska-Zajac et al.

    Plasma concentration of interleukin 6 (IL-6), and its relationship with circulating concentration of dehydroepiandrosterone sulfate (DHEA-S) in patients with chronic idiopathic urticaria

    Cytokine

    (2007)
  • F. Andre et al.

    Exogenous oestrogen as an alternative to food allergy in the aetiology of angioneurotic oedema

    Toxicology

    (2003)
  • M. Schatz et al.

    Asthma and allergy in pregnancy

    Clin Perinatol

    (1997)
  • Z. Brzoza et al.

    Pruritic urticarial papules and plaques of pregnancy

    J Midwifery Womens Health

    (2007)
  • A.L. Schocket

    Chronic urticaria: pathophysiology and etiology, or the what and why

    Allergy Asthma Proc

    (2006)
  • M. Hide et al.

    Autoantibodies against the high-affinity IgE receptor as a cause of histamine release in chronic urticaria

    N Engl J Med

    (1993)
  • L. Bertinotti et al.

    Angioedema and systemic sclerosis. A review of the literature

    Scand J Rheumatol

    (2002)
  • M. Aversano et al.

    Improvement of chronic idiopathic urticaria with l-thyroxine: a new TSH role in immune response?

    Allergy

    (2005)
  • C.J. Gibbs et al.

    Premenstrual exacerbation of asthma

    Thorax

    (1984)
  • H.L.C. Beynon et al.

    Severe premenstrual exacerbations of asthma: effect of intramuscular progesterone

    Lancet

    (1988)
  • D. Kemmett

    Premenstrual exacerbation of atopic dermatitis

    Br J Dermatol

    (1989)
  • J.A. Yell et al.

    The effect of hormonal changes on cutaneous disease in lupus erythematosus

    Br J Dermatol

    (1993)
  • A. Agostoni et al.

    Hereditary and acquired angioedema: problems and progress: proceedings of the third C1 esterase inhibitor deficiency workshop and beyond

    J Allergy Clin Immunol

    (2004)
  • J. Yip et al.

    Hormonally exacerbated hereditary angioedema

    Australas J Dermatol

    (1992)
  • B. Visy et al.

    Sex hormones in hereditary angioneurotic oedema

    Clin Endocrinol (Oxf)

    (2004)
  • Y.A. Buss et al.

    Chronic urticaria—which clinical parameters are pathogenetically relevant? A retrospective investigation of 339 patients

    J Dtsch Dermatol Ges

    (2007)
  • M.W. Greaves

    Chronic urticaria

    N Engl J Med

    (1995)
  • Cited by (63)

    • Hormonal Effects on Urticaria and Angioedema Conditions

      2021, Journal of Allergy and Clinical Immunology: In Practice
      Citation Excerpt :

      In general, CSU is more prevalent in women from after puberty until menopause, but this prevalence is not as apparent before puberty or after menopause, likely owing to hormonal influences. Sex hormones are thought to be responsible for sex differential susceptibility and the severity of some immune-mediated diseases including CU.26 However, contrary to bradykinin-induced AE, in which the role of sex hormones is clearly demonstrated, their impact on the clinical course and severity of urticaria is modest.

    • Emerging Causes of Drug-Induced Anaphylaxis: A Review of Anaphylaxis-Associated Reports in the FDA Adverse Event Reporting System (FAERS)

      2021, Journal of Allergy and Clinical Immunology: In Practice
      Citation Excerpt :

      To put our findings in context, reports of anaphylaxis to FAERS increased year over year from 1999 to 2019.14-18 A total of 62.71% of all reports of anaphylaxis to the FDA in our study period were female, reflecting a previously reported female bias toward anaphylaxis,14-16,19-21 including drugs associated with non–IgE-mediated mast cell activation and urticaria that is noted to be both dose and weight based and potentially more common in women.22 The notable exception was cetuximab, a drug used to treat head and neck tumors that are more prevalent in men.23

    • Orolingual angioedema after thrombolysis is not associated with insular cortex ischemia on pre-thrombolysis CT

      2016, Journal of the Neurological Sciences
      Citation Excerpt :

      Other case control-studies found a higher frequency of OA in women [3,5] and, in our study, female sex was an independent risk factor for OA, which is in accordance to a large cohort study of medication-related angioedema incidence [9]. The reason for this sex difference is not clear, but may include the influence of sex hormones on the regulation of inflammation and an increased Th2 immune response in women [10], which is further supported by the female predominance of chronic urticaria, a condition with a pathophysiology closely linked to acquired angioedema [11]. Current use of ACE-I was independently associated with a 4-fold risk increase in the development of OA.

    • Urticaria and Angioedema

      2016, Pediatric Allergy: Principles and Practice: Third Edition
    View all citing articles on Scopus
    View full text